SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-21-333965
Filing Date
2021-11-18
Accepted
2021-11-18 17:07:59
Documents
11

Document Format Files

Seq Description Document Type Size
1 SC14D9C d262144dsc14d9c.htm SC14D9C 19812
2 EX-99.1 d262144dex991.htm EX-99.1 17012
3 EX-99.2 d262144dex992.htm EX-99.2 35960
4 EX-99.3 d262144dex993.htm EX-99.3 1247
5 EX-99.4 d262144dex994.htm EX-99.4 3561
6 EX-99.5 d262144dex995.htm EX-99.5 12064
7 EX-99.6 d262144dex996.htm EX-99.6 913
8 GRAPHIC g262144g1118231228321.jpg GRAPHIC 29140
9 GRAPHIC g262144g1118231228649.jpg GRAPHIC 25976
10 GRAPHIC g262144g1118231537494.jpg GRAPHIC 18906
11 GRAPHIC g262144g1118231537728.jpg GRAPHIC 40943
  Complete submission text file 0001193125-21-333965.txt   251027
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filed by) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87866 | Film No.: 211425270
SIC: 2834 Pharmaceutical Preparations